Bio-Thera Solutions, Ltd

Bio-Thera Announces NMPA Approval of BAT2506, the First Golimumab Biosimilar Approved in China

Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced…